Hyperfine (NASDAQ:HYPR) Price Target Cut to $1.20 by Analysts at B. Riley

Hyperfine (NASDAQ:HYPRFree Report) had its price objective reduced by B. Riley from $1.50 to $1.20 in a research note released on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.

Separately, Wells Fargo & Company lifted their price target on shares of Hyperfine from $1.10 to $1.29 and gave the stock an “equal weight” rating in a report on Tuesday, March 18th.

View Our Latest Stock Report on Hyperfine

Hyperfine Price Performance

Shares of NASDAQ HYPR opened at $0.82 on Thursday. The company has a market cap of $59.82 million, a PE ratio of -1.44 and a beta of 0.94. Hyperfine has a 12 month low of $0.76 and a 12 month high of $1.90. The company has a 50-day simple moving average of $1.06 and a 200-day simple moving average of $1.00.

Hyperfine (NASDAQ:HYPRGet Free Report) last issued its quarterly earnings results on Monday, March 17th. The company reported ($0.14) EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.02. The business had revenue of $2.32 million during the quarter, compared to the consensus estimate of $2.30 million. Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%. During the same period in the previous year, the firm posted ($0.15) earnings per share. On average, analysts anticipate that Hyperfine will post -0.57 EPS for the current year.

Institutional Investors Weigh In On Hyperfine

Institutional investors have recently bought and sold shares of the stock. Virtu Financial LLC purchased a new stake in Hyperfine in the fourth quarter valued at approximately $25,000. Graypoint LLC purchased a new stake in Hyperfine in the fourth quarter valued at approximately $44,000. Wealth Enhancement Advisory Services LLC grew its holdings in Hyperfine by 64.3% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company’s stock valued at $72,000 after purchasing an additional 32,093 shares during the period. Renaissance Technologies LLC grew its holdings in Hyperfine by 32.9% in the fourth quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock valued at $187,000 after purchasing an additional 52,500 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Hyperfine by 18.7% in the third quarter. Geode Capital Management LLC now owns 624,520 shares of the company’s stock valued at $675,000 after purchasing an additional 98,335 shares during the period. 15.03% of the stock is currently owned by hedge funds and other institutional investors.

Hyperfine Company Profile

(Get Free Report)

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

See Also

Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.